List of partners

The Consortium of the initial EBiSC project (2014-2017) represented all relevant stakeholders from tissue donors to clinical and academic iPSC researchers and industrial users to provide the scientific expertise, facilities, networks and experience required to achieve the European Bank for induced pluripotent Stem Cells and respond appropriately to advances in science and society.

Led by Janssen Pharmaceutica and managed by Roslin Cells Sciences Ltd., the Consortium comprised during the initial project phase (2014-2017) eight active participant iPSC Centres with clinical and patient networks, a global leader in industrial iPSC supply, international experts in iPSC science, biobanking, bioengineering, regenerative medicine and data management, and scholars in law and ethics.

For the second project phase (2019-2022) the EBiSC2 Consortium concentrates on key partners with the necessary core expertise, knowledge and operational capacity to achieve the EBiSC bank's sustainability and bundle the necessary financial resources. The Consortium is again led by Janssen Pharmaceutica and now coordinated by Fraunhofer IBMT.